Carson Wealth (CWM LLC)
SUPN icon

Carson Wealth (CWM LLC)’s Supernus Pharmaceuticals SUPN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Sell
3,112
-104
-3% -$5.3K ﹤0.01% 2909
2025
Q4 		$160K Sell
3,216
-440
-12% -$21.4K ﹤0.01% 2742
2025
Q3 		$175K Buy
3,656
+576
+19% +$23.2K ﹤0.01% 2545
2025
Q2 		$97K Buy
3,080
+1,479
+92% +$47.4K ﹤0.01% 2764
2025
Q1 		$52K Sell
1,601
-72
-4% -$2.55K ﹤0.01% 2963
2024
Q4 		$60K Buy
1,673
+450
+37% +$15.8K ﹤0.01% 2670
2024
Q3 		$38K Buy
1,223
+424
+53% +$13.2K ﹤0.01% 2914
2024
Q2 		$21K Sell
799
-118
-13% -$3.42K ﹤0.01% 3093
2024
Q1 		$31K Buy
917
+119
+15% +$3.54K ﹤0.01% 2629
2023
Q4 		$23K Buy
798
+611
+327% +$16.2K ﹤0.01% 2706
2023
Q3 		$5K Buy
187
+19
+11% +$578 ﹤0.01% 3495
2023
Q2 		$5K Sell
168
-171
-50% -$5.98K ﹤0.01% 3470
2023
Q1 		$12K Buy
339
+72
+27% +$2.77K ﹤0.01% 2865
2022
Q4 		$10K Sell
267
-15
-5% -$521 ﹤0.01% 2813
2022
Q3 		$10K Buy
282
+99
+54% +$3.22K ﹤0.01% 2703
2022
Q2 		$5K Hold
183
– – ﹤0.01% 3013
2022
Q1 		$6K Sell
183
-18
-9% -$552 ﹤0.01% 2785
2021
Q4 		$6K Buy
+201
New +$6.1K ﹤0.01% 2668
2021
Q2 		$2K Hold
59
– – ﹤0.01% 2701
2021
Q1 		$2K Hold
59
– – ﹤0.01% 2701
2020
Q4 		$2K Hold
59
– – ﹤0.01% 2700
2020
Q3 		$2K Hold
59
– – ﹤0.01% 2699
2020
Q2 		$2K Hold
59
– – ﹤0.01% 2698
2020
Q1 		$2K Hold
59
– – ﹤0.01% 2698
2019
Q4 		$2K Hold
59
– – ﹤0.01% 2697
2019
Q3 		$2K Hold
59
– – ﹤0.01% 2697
2019
Q2 		$2K Hold
59
– – ﹤0.01% 2696
2019
Q1 		$2K Buy
+59
New +$2.19K ﹤0.01% 2693

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carson Wealth (CWM LLC)'s SUPN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Supernus Pharmaceuticals (SUPN) stake by 3.2% in Q1 2026, selling an estimated $5.3K and leaving 3,112 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

Carson Wealth (CWM LLC) first reported a position in SUPN in Q1 2019 and has held it in 28 quarters since. The position peaked at $175K in Q3 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 3,112 shares of Supernus Pharmaceuticals worth $161K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 104 Supernus Pharmaceuticals shares in Q1 2026, an estimated $5.3K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2909 holding.
  • Carson Wealth (CWM LLC) first reported a position in Supernus Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Supernus Pharmaceuticals position peaked at $175K in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.